BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2788981)

  • 21. A human hybrid hybridoma.
    Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
    J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On chip electrofusion of single human B cells and mouse myeloma cells for efficient hybridoma generation.
    Kemna EW; Wolbers F; Vermes I; van den Berg A
    Electrophoresis; 2011 Nov; 32(22):3138-46. PubMed ID: 22025094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
    Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
    Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of hybridomas producing multispecific IgM in human x (human-mouse) fusions with lymphocytes from different human immune compartments.
    Jahn S; Schwab J; Kiessig ST; Lukowsky A; Huhnholtz K; Mehl M; Specht U; Grunow R; von Baehr R
    Allerg Immunol (Leipz); 1989; 35(4):271-7. PubMed ID: 2624250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human monoclonal antibody specific for tetanus toxoid.
    Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
    Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monoclonal antibodies : application of B cell hybridomas to biochemical research (author's transl)].
    Tanaka S
    Tanpakushitsu Kakusan Koso; 1981 Jul; 26(8):965-76. PubMed ID: 7031777
    [No Abstract]   [Full Text] [Related]  

  • 29. Increase of hybridoma formation by human lymphocytes after stimulation in vitro; effect of antigen, endothelial cells, and PWM.
    Astaldi GC; Wright EP; Willems C; Zeijlemaker WP; Janssen MC
    J Immunol; 1982 Jun; 128(6):2539-42. PubMed ID: 6804563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoclonal antibodies: methods and clinical laboratory applications.
    Nakamura RM
    Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Human monoclonal antibodies with human-mouse hybridomas].
    Naoe T; Kato K; Shiku H; Yamada K
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2575-81. PubMed ID: 6606396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incorporation of T cell counterparts in the fusion partners for generation of human monoclonal antibodies from Staphylococcus aureus stimulated B lymphocytes.
    Gore MM; Singhania SS; Basu A; Banerjee K
    Hum Antibodies; 1997; 8(1):26-32. PubMed ID: 9265502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Attempts to improve hybridoma technology for the production of human monoclonal antibodies].
    Tokunaga T; Chiba J; Ohnishi K
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2198-204. PubMed ID: 3038035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.
    Kametani Y; Shiina M; Katano I; Ito R; Ando K; Toyama K; Tsukamoto H; Matsumura T; Saito Y; Ishikawa D; Taki T; Ito M; Imai K; Tokuda Y; Kato S; Tamaoki N; Habu S
    Exp Hematol; 2006 Sep; 34(9):1240-8. PubMed ID: 16939817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human hybrid myeloma for production of human monoclonal antibodies.
    Kozbor D; Tripputi P; Roder JC; Croce CM
    J Immunol; 1984 Dec; 133(6):3001-5. PubMed ID: 6092464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
    Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
    Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
    [No Abstract]   [Full Text] [Related]  

  • 38. [Hybridomas synthesizing monoclonal antibodies to surface antigens of human lymphocytes].
    Seregina TM; Mekshenkov MI
    Tsitologiia; 1986 Sep; 28(9):976-80. PubMed ID: 3798564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of monoclonal antibodies in swine.
    Lumanglas AL; Wang BS
    Methods Mol Biol; 1995; 45():49-54. PubMed ID: 7550691
    [No Abstract]   [Full Text] [Related]  

  • 40. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.